Nagano, Japan

Arao Ujiie


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Nagano, JP (1991 - 1994)
  • Toyoshina-machi, JP (2000)

Company Filing History:


Years Active: 1991-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arao Ujiie

Introduction

Arao Ujiie is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of various medical conditions. With a total of 4 patents to his name, Ujiie's work has had a meaningful impact on healthcare.

Latest Patents

Ujiie's latest patents include a method for the treatment or prevention of restenosis associated with coronary intervention. This method involves administering compounds of the class of aminobenzoic acids, specifically 2-(3,4-dimethoxy-cinnamoyl)-aminobenzoic acid or its pharmaceutically acceptable salt. The dosage is designed to maintain the plasma concentration at about 100 μmol for a period of less than three months. Another significant patent involves piperidino-3,4-dihydrocarbostyril compounds, which exhibit platelet aggregation inhibiting activity. These compounds are useful as therapeutic agents for the prevention or treatment of cerebral ischemic disorders and arterial ischemic disorders.

Career Highlights

Ujiie is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to improving patient outcomes through advanced medical treatments.

Collaborations

Ujiie has collaborated with notable colleagues such as Tetsuhide Kamijo and Hiromu Harada. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Arao Ujiie's contributions to the field of pharmaceuticals exemplify the importance of innovation in healthcare. His patents reflect a dedication to addressing critical medical challenges and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…